{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["anti-inflammatory", "anti-senescence", "antibacterial", "antioxidant", "antiparasitic", "inflammation", "natural compound", "plumbagin", "plumbaginaceae", "stem cells"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37374085", "DateRevised": {"Year": "2023", "Month": "07", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "05", "Day": "31"}], "Language": ["eng"], "ELocationID": ["1303", "10.3390/life13061303"], "Journal": {"ISSN": "2075-1729", "JournalIssue": {"Volume": "13", "Issue": "6", "PubDate": {"Year": "2023", "Month": "May", "Day": "31"}}, "Title": "Life (Basel, Switzerland)", "ISOAbbreviation": "Life (Basel)"}, "ArticleTitle": "Plumbagin, a Natural Compound with Several Biological Effects and Anti-Inflammatory Properties.", "Abstract": {"AbstractText": ["Phytochemicals from various medicinal plants are well known for their antioxidant properties and anti-cancer effects. Many of these bioactive compounds or natural products have demonstrated effects against inflammation, while some showed a role that is only approximately described as anti-inflammatory. In particular, naphthoquinones are naturally-occurring compounds with different pharmacological activities and allow easy scaffold modification for drug design approaches. Among this class of compounds, Plumbagin, a plant-derived product, has shown interesting counteracting effects in many inflammation models. However, scientific knowledge about the beneficial effect of Plumbagin should be comprehensively reported before candidating this natural molecule into a future drug against specific human diseases. In this review, the most relevant mechanisms in which Plumbagin plays a role in the process of inflammation were summarized. Other relevant bioactive effects were reviewed to provide a complete and compact scenario of Plumbagin's potential therapeutic significance."]}, "AuthorList": [{"Identifier": ["0000-0002-7114-9588"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical and Surgical Sciences, University of Bologna, 40126 Bologna, BO, Italy."}], "LastName": "Petrocelli", "ForeName": "Giovannamaria", "Initials": "G"}, {"Identifier": ["0000-0001-6644-5828"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical and Surgical Sciences, University of Bologna, 40126 Bologna, BO, Italy."}], "LastName": "Marrazzo", "ForeName": "Pasquale", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical and Surgical Sciences, University of Bologna, 40126 Bologna, BO, Italy."}], "LastName": "Bonsi", "ForeName": "Laura", "Initials": "L"}, {"Identifier": ["0000-0002-7886-3186"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical and Surgical Sciences, University of Bologna, 40126 Bologna, BO, Italy."}], "LastName": "Facchin", "ForeName": "Federica", "Initials": "F"}, {"Identifier": ["0000-0002-5315-0104"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical and Neuromotor Science, University of Bologna, 40126 Bologna, BO, Italy."}], "LastName": "Alviano", "ForeName": "Francesco", "Initials": "F"}, {"Identifier": ["0000-0003-3857-0677"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical and Surgical Sciences, University of Bologna, 40126 Bologna, BO, Italy."}], "LastName": "Canaider", "ForeName": "Silvia", "Initials": "S"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Life (Basel)", "NlmUniqueID": "101580444", "ISSNLinking": "2075-1729"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Padhye S., Dandawate P., Yusufi M., Ahmad A., Sarkar F.H. Perspectives on medicinal properties of plumbagin and its analogs. Med. Res. Rev. 2012;32:1131\u20131158. doi: 10.1002/med.20235.", "ArticleIdList": ["10.1002/med.20235", "23059762"]}, {"Citation": "Aziz M.H., Dreckschmidt N.E., Verma A.K. Plumbagin, a medicinal plant-derived naphthoquinone, is a novel inhibitor of the growth and invasion of hormone-refractory prostate cancer. Cancer Res. 2008;68:9024\u20139032. doi: 10.1158/0008-5472.CAN-08-2494.", "ArticleIdList": ["10.1158/0008-5472.CAN-08-2494", "PMC2584362", "18974148"]}, {"Citation": "Shivani D., Venkatesh, D\u2019Souza R., Shenoy B.D., Udupi R.H., Udupa N. Niosomal delivery of plumbagin ester for better anti-fertility activity. Indian Drugs. 2002;39:163\u2013165."}, {"Citation": "Ahmad I., Mehmood Z., Mohammad F., Ahmad S. Antimicrobial potency and synergistic activity of five traditionally used Indian medicinal plants. J. Med. Aromat. Plant Sci. 2000;23:173\u2013176."}, {"Citation": "Jeyachandran R., Mahesh A., Cindrella L., Sudhakar S., Pazhanichamy K. Antibacterial activity of plumbagin and root extracts of Plumbago zeylanica L. Acta Biol. Crac. Ser. Bot. 2009;51:17\u201322."}, {"Citation": "Oyedapo O.O. Studies on Bioactivity of the Root Extract of Plumbago zeylanica. Int. J. Pharmacogn. 1996;34:365\u2013369. doi: 10.1076/phbi.34.5.365.13249.", "ArticleIdList": ["10.1076/phbi.34.5.365.13249"]}, {"Citation": "Panichayupakaranant P., Ahmad M.I. Plumbagin and its role in chronic diseases. Adv. Exp. Med. Biol. 2016;929:229\u2013246. doi: 10.1007/978-3-319-41342-6_10.", "ArticleIdList": ["10.1007/978-3-319-41342-6_10", "27771927"]}, {"Citation": "Shukla B., Saxena S., Usmani S., Kushwaha P. Phytochemistry and pharmacological studies of Plumbago zeylanica L.: A medicinal plant review. Clin. Phytosci. 2021;7:34. doi: 10.1186/s40816-021-00271-7.", "ArticleIdList": ["10.1186/s40816-021-00271-7"]}, {"Citation": "Hafeez B.B., Zhong W., Fischer J.W., Mustafa A., Shi X., Meske L., Hong H., Cai W., Havighurst T., Kim K., et al. Plumbagin, a medicinal plant (Plumbago zeylanica)-derived 1,4-naphthoquinone, inhibits growth and metastasis of human prostate cancer PC-3M-luciferase cells in an orthotopic xenograft mouse model. Mol. Oncol. 2013;7:428\u2013439. doi: 10.1016/j.molonc.2012.12.001.", "ArticleIdList": ["10.1016/j.molonc.2012.12.001", "PMC3625495", "23273564"]}, {"Citation": "Yadav A.M., Bagade M.M., Ghumnani S., Raman S., Saha B., Kubatzky K.F., Ashma R. The phytochemical plumbagin reciprocally modulates osteoblasts and osteoclasts. Biol. Chem. 2021;403:211\u2013229. doi: 10.1515/hsz-2021-0290.", "ArticleIdList": ["10.1515/hsz-2021-0290", "34882360"]}, {"Citation": "Hsieh Y.J., Lin L.C., Tsai T.H. Measurement and pharmacokinetic study of plumbagin in a conscious freely moving rat using liquid chromatography/tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2006;844:1\u20135. doi: 10.1016/j.jchromb.2006.06.024.", "ArticleIdList": ["10.1016/j.jchromb.2006.06.024", "16837255"]}, {"Citation": "Nair H.A., Snima K.S., Kamath R.C., Nair S.V., Lakshmanan V.K. Plumbagin nanoparticles induce dose and pH dependent toxicity on prostate cancer cells. Curr. Drug Deliv. 2015;12:709\u2013716. doi: 10.2174/1567201812666150316150033.", "ArticleIdList": ["10.2174/1567201812666150316150033", "25772029"]}, {"Citation": "Tripathi S.K., Panda M., Biswal B.K. Emerging role of plumbagin: Cytotoxic potential and pharmaceutical relevance towards cancer therapy. Food Chem. Toxicol. 2019;125:566\u2013582. doi: 10.1016/j.fct.2019.01.018.", "ArticleIdList": ["10.1016/j.fct.2019.01.018", "30685472"]}, {"Citation": "Thakor N., Janathia B. Plumbagin: A potential candidate for future research and development. Curr. Pharm. Biotechnol. 2022;23:1800\u20131812. doi: 10.2174/1389201023666211230113146.", "ArticleIdList": ["10.2174/1389201023666211230113146", "34967293"]}, {"Citation": "Sukkasem N., Chatuphonprasert W., Tatiya-Aphiradee N., Jarukamjorn K. Imbalance of the antioxidative system by plumbagin and Plumbago indica L. extract induces hepatotoxicity in mice. J. Intercult. Ethnopharmacol. 2016;24:137\u2013145. doi: 10.5455/jice.20160301094913.", "ArticleIdList": ["10.5455/jice.20160301094913", "PMC4835988", "27104034"]}, {"Citation": "Avila-Carrasco L., Majano P., S\u00e1nchez-Tom\u00e9ro J.A., Selgas R., L\u00f3pez-Cabrera M., Aguilera A., Gonz\u00e1lez Mateo G. Natural plants compounds as modulators of epithelial-to-mesenchymal transition. Front. Pharmacol. 2019;10:715. doi: 10.3389/fphar.2019.00715.", "ArticleIdList": ["10.3389/fphar.2019.00715", "PMC6682706", "31417401"]}, {"Citation": "Yin Z., Zhang J., Chen L., Guo Q., Yang B., Zhang W., Kang W. Anticancer effects and mechanisms of action of plumbagin: Review of research advances. Biomed. Res. Int. 2020;2020:6940953. doi: 10.1155/2020/6940953.", "ArticleIdList": ["10.1155/2020/6940953", "PMC7725562", "33344645"]}, {"Citation": "Luo P., Wong Y.F., Ge L., Zhang Z.F., Liu Y., Liu L., Zhou H. Anti-inflammatory and analgesic effect of plumbagin through inhibition of nuclear factor-\u03baB activation. J. Pharmacol. Exp. Ther. 2010;335:735\u2013742. doi: 10.1124/jpet.110.170852.", "ArticleIdList": ["10.1124/jpet.110.170852", "20858709"]}, {"Citation": "Wang T., Wu F., Jin Z., Zhai Z., Wang Y., Tu B., Yan W., Tang T. Plumbagin inhibits LPS-induced inflammation through the inactivation of the nuclear factor-kappa B and mitogen activated protein kinase signaling pathways in RAW 264.7 cells. Food Chem. Toxicol. 2014;64:177\u2013183. doi: 10.1016/j.fct.2013.11.027.", "ArticleIdList": ["10.1016/j.fct.2013.11.027", "24296134"]}, {"Citation": "Checker R., Patwardhan R.S., Sharma D., Menon J., Thoh M., Sandur S.K., Sainis K.B., Poduval T.B. Plumbagin, a vitamin K3 analogue, abrogates lipopolysaccharide-induced oxidative stress, inflammation and endotoxic shock via NF-kappaB suppression. Inflammation. 2014;37:542\u2013554. doi: 10.1007/s10753-013-9768-y.", "ArticleIdList": ["10.1007/s10753-013-9768-y", "24234154"]}, {"Citation": "Guo Y.X., Liu L., Yan D.Z., Guo J.P. Plumbagin prevents osteoarthritis in human chondrocytes through Nrf-2 activation. Mol. Med. Rep. 2017;15:2333\u20132338. doi: 10.3892/mmr.2017.6234.", "ArticleIdList": ["10.3892/mmr.2017.6234", "28259976"]}, {"Citation": "Kuan-Hong W., Bai-Zhou L. Plumbagin protects against hydrogen peroxide-induced neurotoxicity by modulating NF-\u03baB and Nrf-2. Arch. Med. Sci. 2018;14:1112\u20131118. doi: 10.5114/aoms.2016.64768.", "ArticleIdList": ["10.5114/aoms.2016.64768", "PMC6111359", "30154895"]}, {"Citation": "Zhang W., Cheng L., Hou Y., Si M., Zhao Y.P., Nie L. Plumbagin protects against spinal cord injury-induced oxidative stress and inflammation in wistar rats through Nrf-2 upregulation. Drug Res. 2015;65:495\u2013499. doi: 10.1055/s-0034-1389950.", "ArticleIdList": ["10.1055/s-0034-1389950", "25243650"]}, {"Citation": "Zhang S., Li D., Yang J.Y., Yan T.B. Plumbagin protects against glucocorticoid-induced osteoporosis through Nrf-2 pathway. Cell Stress Chaperones. 2015;20:621\u2013629. doi: 10.1007/s12192-015-0585-0.", "ArticleIdList": ["10.1007/s12192-015-0585-0", "PMC4463920", "25939783"]}, {"Citation": "Chu H., Yu H., Ren D., Zhu K., Huang H. Plumbagin exerts protective effects in nucleus pulposus cells by attenuating hydrogen peroxide-induced oxidative stress, inflammation and apoptosis through NF-\u03baB and Nrf-2. Int. J. Mol. Med. 2016;37:1669\u20131676. doi: 10.3892/ijmm.2016.2564.", "ArticleIdList": ["10.3892/ijmm.2016.2564", "27082014"]}, {"Citation": "Zaki A.M., El-Tanbouly D.M., Abdelsalam R.M., Zaki H.F. Plumbagin ameliorates hepatic ischemia-reperfusion injury in rats: Role of high mobility group box 1 in inflammation, oxidative stress and apoptosis. Biomed. Pharmacother. 2018;106:785\u2013793. doi: 10.1016/j.biopha.2018.07.004.", "ArticleIdList": ["10.1016/j.biopha.2018.07.004", "29990872"]}, {"Citation": "Chen X.J., Zhang J.G., Wu L. Plumbagin inhibits neuronal apoptosis, intimal hyperplasia and also suppresses TNF-\u03b1/NF-\u03baB pathway induced inflammation and matrix metalloproteinase-2/9 expression in rat cerebral ischemia. Saudi J. Biol. Sci. 2018;25:1033\u20131039. doi: 10.1016/j.sjbs.2017.03.006.", "ArticleIdList": ["10.1016/j.sjbs.2017.03.006", "PMC6116857", "30174499"]}, {"Citation": "Zhang Q., Zhao S., Zheng W., Fu H., Wu T., Hu F. Plumbagin attenuated oxygen-glucose deprivation/reoxygenation-induced injury in human SH-SY5Y cells by inhibiting NOX4-derived ROS-activated NLRP3 inflammasome. Biosci. Biotechnol. Biochem. 2020;84:134\u2013142. doi: 10.1080/09168451.2019.1664893.", "ArticleIdList": ["10.1080/09168451.2019.1664893", "31490096"]}, {"Citation": "Marrazzo P., Angeloni C., Hrelia S. Combined treatment with three natural antioxidants enhances neuroprotection in a SH-SY5Y 3D culture model. Antioxidants. 2019;8:420. doi: 10.3390/antiox8100420.", "ArticleIdList": ["10.3390/antiox8100420", "PMC6827135", "31547034"]}, {"Citation": "Wang H., Zhang H., Zhang Y., Wang D., Cheng X., Yang F., Zhang Q., Xue Z., Li Y., Zhang L., et al. Plumbagin protects liver against fulminant hepatic failure and chronic liver fibrosis via inhibiting inflammation and collagen production. Oncotarget. 2016;7:82864\u201382875. doi: 10.18632/oncotarget.12655.", "ArticleIdList": ["10.18632/oncotarget.12655", "PMC5347738", "27756878"]}, {"Citation": "Pan P.H., Wang Y.Y., Lin S.Y., Liao S.L., Chen Y.F., Huang W.C., Chen C.J., Chen W.Y. Plumbagin ameliorates bile duct ligation-induced cholestatic liver injury in rats. Biomed. Pharmacother. 2022;151:113133. doi: 10.1016/j.biopha.2022.113133.", "ArticleIdList": ["10.1016/j.biopha.2022.113133", "35594710"]}, {"Citation": "Vaduganathan M., Mensah G.A., Turco J.V., Fuster V., Roth G.A. The global burden of cardiovascular diseases and risk: A compass for future health. J. Am. Coll. Cardiol. 2022;80:2361\u20132371. doi: 10.1016/j.jacc.2022.11.005.", "ArticleIdList": ["10.1016/j.jacc.2022.11.005", "36368511"]}, {"Citation": "McGowan J.V., Chung R., Maulik A., Piotrowska I., MalcolmWalker J., Yellon D.M. Anthracycline chemotherapy and cardiotoxicity. Cardiovasc. Drugs Ther. 2017;31:63\u201375. doi: 10.1007/s10557-016-6711-0.", "ArticleIdList": ["10.1007/s10557-016-6711-0", "PMC5346598", "28185035"]}, {"Citation": "Li Z., Chinnathambi A., Ali Alharbi S., Yin F. Plumbagin protects the myocardial damage by modulating the cardiac biomarkers, antioxidants, and apoptosis signaling in the doxorubicin-induced cardiotoxicity in rats. Environ. Toxicol. 2020;35:1374\u20131385. doi: 10.1002/tox.23002.", "ArticleIdList": ["10.1002/tox.23002", "32691977"]}, {"Citation": "Zhang Q., Fu H., Gong W., Cao F., Wu T., Hu F. Plumbagin protects H9c2 cardiomyocytes against TBHP-induced cytotoxicity by alleviating ROS-induced apoptosis and modulating autophagy. Exp. Ther. Med. 2022;24:501. doi: 10.3892/etm.2022.11428.", "ArticleIdList": ["10.3892/etm.2022.11428", "PMC9257763", "35837065"]}, {"Citation": "Haddad J.J., Harb H.L. L-gamma-Glutamyl-L-cysteinyl-glycine (glutathione; GSH) and GSH-related enzymes in the regulation of pro- and anti-inflammatory cytokines: A signaling transcriptional scenario for redox(y) immunologic sensor(s)? Mol. Immunol. 2005;42:987\u20131014. doi: 10.1016/j.molimm.2004.09.029.", "ArticleIdList": ["10.1016/j.molimm.2004.09.029", "15829290"]}, {"Citation": "Checker R., Sharma D., Sandur S.K., Subrahmanyam G., Krishnan S., Poduval T.B., Sainis K.B. Plumbagin inhibits proliferative and inflammatory responses of T cells independent of ROS generation but by modulating intracellular thiols. J. Cell. Biochem. 2010;110:1082\u20131093. doi: 10.1002/jcb.22620.", "ArticleIdList": ["10.1002/jcb.22620", "PMC3065107", "20564204"]}, {"Citation": "Zhang Z., Deng W., Kang R., Xie M., Billiar T., Wang H., Cao L., Tang D. Plumbagin protects mice from lethal sepsis by modulating immunometabolism upstream of PKM2. Mol. Med. 2016;22:162\u2013172. doi: 10.2119/molmed.2015.00250.", "ArticleIdList": ["10.2119/molmed.2015.00250", "PMC5004715", "26982513"]}, {"Citation": "Arruri V., Komirishetty P., Areti A., Dungavath S.K.N., Kumar A. Nrf2 and NF-\u03baB modulation by Plumbagin attenuates functional, behavioural and biochemical deficits in rat model of neuropathic pain. Pharmacol. Rep. 2017;69:625\u2013632. doi: 10.1016/j.pharep.2017.02.006.", "ArticleIdList": ["10.1016/j.pharep.2017.02.006", "28505604"]}, {"Citation": "Messeha S.S., Zarmouh N.O., Mendonca P., Kolta M.G., Soliman K.F.A. The attenuating effects of plumbagin on pro-inflammatory cytokine expression in LPS-activated BV-2 microglial cells. J. Neuroimmunol. 2017;313:129\u2013137. doi: 10.1016/j.jneuroim.2017.09.007.", "ArticleIdList": ["10.1016/j.jneuroim.2017.09.007", "PMC5696062", "28950995"]}, {"Citation": "Chiocchio I., Prata C., Mandrone M., Ricciardiello F., Marrazzo P., Tomasi P., Angeloni C., Fiorentini D., Malaguti M., Poli F., et al. Leaves and spiny burs of Castanea Sativa from an experimental chestnut grove: Metabolomic analysis and anti-neuroinflammatory activity. Metabolites. 2020;10:408. doi: 10.3390/metabo10100408.", "ArticleIdList": ["10.3390/metabo10100408", "PMC7601974", "33066101"]}, {"Citation": "Marrazzo P., Mandrone M., Chiocchio I., Zambonin L., Barbalace M.C., Zalambani C., Angeloni C., Malaguti M., Prata C., Poli F., et al. By-product extracts from Castanea sativa counteract hallmarks of neuroinflammation in a microglial model. Antioxidants. 2023;12:808. doi: 10.3390/antiox12040808.", "ArticleIdList": ["10.3390/antiox12040808", "PMC10135167", "37107183"]}, {"Citation": "Mahmoud I.S., Hatmal M.M., Abuarqoub D., Esawi E., Zalloum H., Wehaibi S., Nsairat H., Alshaer W. 1,4-naphthoquinone is a potent inhibitor of IRAK1 kinases and the production of inflammatory cytokines in THP-1 differentiated macrophages. ACS Omega. 2021;6:25299\u201325310. doi: 10.1021/acsomega.1c03081.", "ArticleIdList": ["10.1021/acsomega.1c03081", "PMC8495692", "34632188"]}, {"Citation": "Jiang Y. Osteoarthritis year in review 2021: Biology. Osteoarthr. Cartil. 2022;30:207\u2013215. doi: 10.1016/j.joca.2021.11.009.", "ArticleIdList": ["10.1016/j.joca.2021.11.009", "34801671"]}, {"Citation": "Marrazzo P., O\u2019Leary C. Repositioning natural antioxidants for therapeutic applications in tissue engineering. Bioengineering. 2020;7:104. doi: 10.3390/bioengineering7030104.", "ArticleIdList": ["10.3390/bioengineering7030104", "PMC7552777", "32887327"]}, {"Citation": "Agarwal S., Misra R., Aggarwal A. Synovial fluid RANKL and matrix metalloproteinase levels in enthesitis related arthritis subtype of juvenile idiopathic arthritis. Rheumatol. Int. 2009;29:907\u2013911. doi: 10.1007/s00296-008-0805-3.", "ArticleIdList": ["10.1007/s00296-008-0805-3", "19052752"]}, {"Citation": "Chemel M., Le Goff B., Brion R., Cozic C., Berreur M., Amiaud J., Bougras G., Touchais S., Blanchard F., Heymann M.F., et al. Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients. Ann. Rheum. Dis. 2012;71:150\u2013154. doi: 10.1136/annrheumdis-2011-200096.", "ArticleIdList": ["10.1136/annrheumdis-2011-200096", "PMC3413617", "22039170"]}, {"Citation": "Udagawa N., Koide M., Nakamura M., Nakamichi Y., Yamashita T., Uehara S., Kobayashi Y., Furuya Y., Yasuda H., Fukuda C., et al. Osteoclast differentiation by RANKL and OPG signaling pathways. J. Bone Miner. Metab. 2021;39:19\u201326. doi: 10.1007/s00774-020-01162-6.", "ArticleIdList": ["10.1007/s00774-020-01162-6", "33079279"]}, {"Citation": "Ainola M., Mandelin J., Liljestr\u00f6m M., Konttinen Y.T., Salo J. Imbalanced expression of RANKL and osteoprotegerin mRNA in pannus tissue of rheumatoid arthritis. Clin. Exp. Rheumatol. 2008;26:240\u2013246.", "ArticleIdList": ["18565244"]}, {"Citation": "Hensvold A.H., Joshua V., Li W., Larkin M., Qureshi F., Israelsson L., Padyukov L., Lundberg K., Defranoux N., Saevarsdottir S., et al. Serum RANKL levels associate with anti- citrullinated protein antibodies in early untreated rheumatoid arthritis and are modulated following methotrexate. Arthritis Res. Ther. 2015;17:239. doi: 10.1186/s13075-015-0760-9.", "ArticleIdList": ["10.1186/s13075-015-0760-9", "PMC4559929", "26337028"]}, {"Citation": "Abimannan T., Peroumal D., Parida J.R., Barik P.K., Padhan P., Devadas S. Oxidative stress modulates the cytokine response of differentiated Th17 and Th1 cells. Free Radic. Biol. Med. 2016;99:352\u2013363. doi: 10.1016/j.freeradbiomed.2016.08.026.", "ArticleIdList": ["10.1016/j.freeradbiomed.2016.08.026", "27567538"]}, {"Citation": "Cui M.Y., Li X., Lei Y.M., Xia L.P., Lu J., Shen H. Effects of IL-34 on the secretion of RANKL/OPG by fibroblast-like synoviocytes and peripheral blood mononuclear cells in rheumatoid arthritis. Eur. Cytokine Netw. 2019;30:67\u201373. doi: 10.1684/ecn.2019.0428.", "ArticleIdList": ["10.1684/ecn.2019.0428", "31486401"]}, {"Citation": "Weinstein R.S. Clinical practice. Glucocorticoid-induced bone disease. N. Engl. J. Med. 2011;365:62\u201370. doi: 10.1056/NEJMcp1012926.", "ArticleIdList": ["10.1056/NEJMcp1012926", "21732837"]}, {"Citation": "Aya K., Alhawagri M., Hagen-Stapleton A., Kitaura H., Kanagawa O., Novack D.V. NF-(kappa)B-inducing kinase controls lymphocyte and osteoclast activities in inflammatory arthritis. J. Clin. Investig. 2005;115:1848\u20131854. doi: 10.1172/JCI23763.", "ArticleIdList": ["10.1172/JCI23763", "PMC1142111", "15937549"]}, {"Citation": "Yamashita T., Yao Z., Li F., Zhang Q., Badell I.R., Schwarz E.M., Takeshita S., Wagner E.F., Noda M., Matsuo K., et al. NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1. J. Biol. Chem. 2007;282:18245\u201318253. doi: 10.1074/jbc.M610701200.", "ArticleIdList": ["10.1074/jbc.M610701200", "17485464"]}, {"Citation": "Yao Z., Getting S.J., Locke I.C. Regulation of TNF-induced osteoclast differentiation. Cells. 2021;11:132. doi: 10.3390/cells11010132.", "ArticleIdList": ["10.3390/cells11010132", "PMC8750957", "35011694"]}, {"Citation": "Shen G., Liu X., Lei W., Duan R., Yao Z. Plumbagin is a NF-\u03baB-inducing kinase inhibitor with dual anabolic and antiresorptive effects that prevents menopausal-related osteoporosis in mice. J. Biol. Chem. 2022;298:101767. doi: 10.1016/j.jbc.2022.101767.", "ArticleIdList": ["10.1016/j.jbc.2022.101767", "PMC8958545", "35235833"]}, {"Citation": "Sultanli S., Ghumnani S., Ashma R., Kubatzky K.F. Plumbagin, a biomolecule with (anti)osteoclastic properties. Int. J. Mol. Sci. 2021;22:2779. doi: 10.3390/ijms22052779.", "ArticleIdList": ["10.3390/ijms22052779", "PMC7967158", "33803472"]}, {"Citation": "Wei Y., Huang M., Liu X., Yuan Z., Peng Y., Huang Z., Duan X., Zhao T. Anti-fibrotic effect of plumbagin on CCl\u2084-lesioned rats. Cell. Physiol. Biochem. 2015;35:1599\u20131608. doi: 10.1159/000373974.", "ArticleIdList": ["10.1159/000373974", "25824458"]}, {"Citation": "Chen S., Chen Y., Chen B., Cai Y.J., Zou Z.L., Wang J.G., Lin Z., Wang X.D., Fu L.Y., Hu Y.R., et al. Plumbagin ameliorates CCl4-induced hepatic fibrosis in rats via the epidermal growth factor receptor signaling pathway. Evid. Based Complement. Altern. Med. 2015;2015:645727. doi: 10.1155/2015/645727.", "ArticleIdList": ["10.1155/2015/645727", "PMC4624924", "26550019"]}, {"Citation": "Chen Y., Zhao C., Liu X., Wu G., Zhong J., Zhao T., Li J., Lin Y., Zhou Y., Wei Y. Plumbagin ameliorates liver fibrosis via a ROS-mediated NF-\u043aB signaling pathway in vitro and in vivo. Biomed. Pharmacother. 2019;116:108923. doi: 10.1016/j.biopha.2019.108923.", "ArticleIdList": ["10.1016/j.biopha.2019.108923", "31154269"]}, {"Citation": "Lee S.Y., Kim M.J., Jang S., Lee G.E., Hwang S.Y., Kwon Y., Hong J.Y., Sohn M.H., Park S.Y., Yoon H.G. Plumbagin suppresses pulmonary fibrosis via inhibition of p300 histone acetyltransferase activity. J. Med. Food. 2020;23:633\u2013640. doi: 10.1089/jmf.2019.4670.", "ArticleIdList": ["10.1089/jmf.2019.4670", "32311286"]}, {"Citation": "Mehdizadeh S., Taherian M., Bayati P., Mousavizadeh K., Pashangzadeh S., Anisian A., Mojtabavi N. Plumbagin attenuates bleomycin-induced lung fibrosis in mice. Allergy Asthma Clin. Immunol. 2022;18:93. doi: 10.1186/s13223-022-00734-7.", "ArticleIdList": ["10.1186/s13223-022-00734-7", "PMC9585773", "36271442"]}, {"Citation": "Shi W., Fang Y., Jiang Y., Jiang S., Li Y., Li W., Xu M., Aschner M., Liu G. Plumbagin attenuates traumatic tracheal stenosis in rats and inhibits lung fibroblast proliferation and differentiation via TGF-\u03b21/Smad and Akt/mTOR pathways. Bioengineered. 2021;12:4475\u20134488. doi: 10.1080/21655979.2021.1954580.", "ArticleIdList": ["10.1080/21655979.2021.1954580", "PMC8806467", "34304701"]}, {"Citation": "Chi\u0219 A.A., Rus L.L., Morgovan C., Arseniu A.M., Frum A., Vonica-\u021aincu A.L., Gligor F.G., Mure\u0219an M.L., Dobrea C.M. Microbial resistance to antibiotics and effective antibiotherapy. Biomedicines. 2022;10:1121. doi: 10.3390/biomedicines10051121.", "ArticleIdList": ["10.3390/biomedicines10051121", "PMC9138529", "35625857"]}, {"Citation": "Marrazzo P., Pizzuti V., Zia S., Sargenti A., Gazzola D., Roda B., Bonsi L., Alviano F. Microfluidic tools for enhanced characterization of therapeutic stem cells and prediction of their potential antimicrobial secretome. Antibiotics. 2021;10:750. doi: 10.3390/antibiotics10070750.", "ArticleIdList": ["10.3390/antibiotics10070750", "PMC8300685", "34206190"]}, {"Citation": "Kapoor N., Kandwal P., Sharma G., Gambhir L. Redox ticklers and beyond: Naphthoquinone repository in the spotlight against inflammation and associated maladies. Pharmacol. Res. 2021;174:105968. doi: 10.1016/j.phrs.2021.105968.", "ArticleIdList": ["10.1016/j.phrs.2021.105968", "34752922"]}, {"Citation": "Singh A.P., Sharma A. Structural insights and pharmaceutical relevance of plumbagin in parasitic disorders: A comprehensive review. Recent Adv. Antiinfect. Drug Discov. 2022;17:187\u2013198. doi: 10.2174/2772434417666220905121531.", "ArticleIdList": ["10.2174/2772434417666220905121531", "36065920"]}, {"Citation": "Hassan S.T., Berchov\u00e1-B\u00edmov\u00e1 K., Petr\u00e1\u0161 J. Plumbagin, a plant-derived compound, exhibits antifungal combinatory effect with amphotericin B against Candida albicans clinical isolates and anti-hepatitis C virus activity. Phytother. Res. 2016;30:1487\u20131492. doi: 10.1002/ptr.5650.", "ArticleIdList": ["10.1002/ptr.5650", "27215409"]}, {"Citation": "Chen X., Yin L., Peng L., Liang Y., Lv H., Ma T. Synergistic effect and mechanism of plumbagin with gentamicin against carbapenem-resistant Klebsiella pneumoniae. Infect. Drug Resist. 2020;13:2751\u20132759. doi: 10.2147/IDR.S265753.", "ArticleIdList": ["10.2147/IDR.S265753", "PMC7432958", "32884304"]}, {"Citation": "Wang Y., Kong J., Zhang X., Liu Y., Huang Z., Yuan L., Zhang Y., Cao J., Chen L., Liu Y., et al. Plumbagin resurrect colistin susceptible against colistin-resistant Pseudomonas aeruginosa in vitro and in vivo. Front. Microbiol. 2022;13:1020652. doi: 10.3389/fmicb.2022.1020652.", "ArticleIdList": ["10.3389/fmicb.2022.1020652", "PMC9579824", "36274701"]}, {"Citation": "Periasamy H., Iswarya S., Pavithra N., Senthilnathan S., Gnanamani A. In vitro antibacterial activity of plumbagin isolated from Plumbago zeylanica L. against methicillin-resistant Staphylococcus aureus. Lett. Appl. Microbiol. 2019;69:41\u201349. doi: 10.1111/lam.13160.", "ArticleIdList": ["10.1111/lam.13160", "31044446"]}, {"Citation": "Dissanayake D.M.I.H., Perera D.D.B.D., Keerthirathna L.R., Heendeniya S., Anderson R.J., Williams D.E., Peiris L.D.C. Antimicrobial activity of Plumbago indica and ligand screening of plumbagin against methicillin-resistant Staphylococcus aureus. J. Biomol. Struct. Dyn. 2022;40:3273\u20133284. doi: 10.1080/07391102.2020.1846622.", "ArticleIdList": ["10.1080/07391102.2020.1846622", "33213303"]}, {"Citation": "Reddy P.J., Ray S., Sathe G.J., Prasad T.S., Rapole S., Panda D., Srivastava S. Proteomics analyses of Bacillus subtilis after treatment with plumbagin, a plant-derived naphthoquinone. OMICS. 2015;19:12\u201323. doi: 10.1089/omi.2014.0099.", "ArticleIdList": ["10.1089/omi.2014.0099", "PMC4281856", "25562197"]}, {"Citation": "Sarkar A., Ghosh S., Shaw R., Patra M.M., Calcuttawala F., Mukherjee N., Das Gupta S.K. Mycobacterium tuberculosis thymidylate synthase (ThyX) is a target for plumbagin, a natural product with antimycobacterial activity. PLoS ONE. 2020;15:e0228657. doi: 10.1371/journal.pone.0228657.", "ArticleIdList": ["10.1371/journal.pone.0228657", "PMC6999906", "32017790"]}, {"Citation": "Awasthi B.P., Kathuria M., Pant G., Kumari N., Mitra K. Plumbagin, a plant-derived naphthoquinone metabolite induces mitochondria mediated apoptosis-like cell death in Leishmania donovani: An ultrastructural and physiological study. Apoptosis. 2016;21:941\u2013953. doi: 10.1007/s10495-016-1259-9.", "ArticleIdList": ["10.1007/s10495-016-1259-9", "27315817"]}, {"Citation": "Chaweeborisuit P., Suriyonplengsaeng C., Suphamungmee W., Sobhon P., Meemon K. Nematicidal effect of plumbagin on Caenorhabditis elegans: A model for testing a nematicidal drug. Z. Naturforsch. C. J. Biosci. 2016;71:121\u2013131. doi: 10.1515/znc-2015-0222.", "ArticleIdList": ["10.1515/znc-2015-0222", "27140303"]}, {"Citation": "Rashidzadeh H., Zamani P., Amiri M., Hassanzadeh S.M., Ramazani A. Nanoincorporation of plumbagin in micelles increase its in vivo anti-plasmodial properties. Iran. J. Parasitol. 2022;17:202\u2013213. doi: 10.18502/ijpa.v17i2.9538.", "ArticleIdList": ["10.18502/ijpa.v17i2.9538", "PMC9363248", "36032752"]}, {"Citation": "Roy A. Plumbagin: A potential anti-cancer compound. Mini Rev. Med. Chem. 2021;21:731\u2013737. doi: 10.2174/1389557520666201116144421.", "ArticleIdList": ["10.2174/1389557520666201116144421", "33200707"]}, {"Citation": "Liu F., Kong X., Lv L., Gao J. TGF-beta1 acts through miR-155 to down-regulate TP53INP1 in promoting epithelial-mesenchymal transition and cancer stem cell phenotypes. Cancer Lett. 2015;359:288\u2013298. doi: 10.1016/j.canlet.2015.01.030.", "ArticleIdList": ["10.1016/j.canlet.2015.01.030", "25633840"]}, {"Citation": "Donnenberg V.S., Donnenberg A.D. Stem cell state and the epithelial to-mesenchymal transition: Implications for cancer therapy. J. Clin. Pharmacol. 2015;55:603\u2013619. doi: 10.1002/jcph.486.", "ArticleIdList": ["10.1002/jcph.486", "25708160"]}, {"Citation": "Pan S.T., Qin Y., Zhou Z.W., He Z.X., Zhang X., Yang T., Yang Y.X., Wang D., Zhou S.F., Qiu J.X. Plumbagin suppresses epithelial to mesenchymal transition and stemness via inhibiting Nrf2-mediated signaling pathway in human tongue squamous cell carcinoma cells. Drug Des. Dev. Ther. 2015;9:5511\u20135551. doi: 10.2147/DDDT.S89621.", "ArticleIdList": ["10.2147/DDDT.S89621", "PMC4599573", "26491260"]}, {"Citation": "Ma I., Allan A.L. The role of human aldehyde dehydrogenase in normal and cancer stem cells. Stem Cell Rev. Rep. 2011;7:292\u2013306. doi: 10.1007/s12015-010-9208-4.", "ArticleIdList": ["10.1007/s12015-010-9208-4", "21103958"]}, {"Citation": "Somasundaram V., Hemalatha S.K., Pal K., Sinha S., Nair A.S., Mukhopadhyay D., Srinivas P. Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells. BMC Cancer. 2016;16:336. doi: 10.1186/s12885-016-2372-4.", "ArticleIdList": ["10.1186/s12885-016-2372-4", "PMC4882782", "27229859"]}, {"Citation": "Reshma R.S., Sreelatha K.H., Somasundaram V., Satheesh Kumar S., Nadhan R., Nair R.S., Srinivas P. Plumbagin, a naphthaquinone derivative induces apoptosis in BRCA 1/2 defective castrate resistant prostate cancer cells as well as prostate cancer stem-like cells. Pharmacol. Res. 2016;105:134\u2013145. doi: 10.1016/j.phrs.2016.01.012.", "ArticleIdList": ["10.1016/j.phrs.2016.01.012", "26808083"]}, {"Citation": "Sakunrangsit N., Ketchart W. Plumbagin inhibits cancer stem-like cells, angiogenesis and suppresses cell proliferation and invasion by targeting Wnt/\u03b2-catenin pathway in endocrine resistant breast cancer. Pharmacol. Res. 2019;150:104517. doi: 10.1016/j.phrs.2019.104517.", "ArticleIdList": ["10.1016/j.phrs.2019.104517", "31693936"]}, {"Citation": "Turinetto V., Vitale E., Giachino C. Senescence in human mesenchymal stem cells: Functional changes and implications in stem cell-based therapy. Int. J. Mol. Sci. 2016;17:1164. doi: 10.3390/ijms17071164.", "ArticleIdList": ["10.3390/ijms17071164", "PMC4964536", "27447618"]}, {"Citation": "Abruzzo P.M., Canaider S., Pizzuti V., Pampanella L., Casadei R., Facchin F., Ventura C. Herb-Derived Products: Natural tools to delay and counteract stem cell senescence. Stem Cells Int. 2020;2020:8827038. doi: 10.1155/2020/8827038.", "ArticleIdList": ["10.1155/2020/8827038", "PMC7568162", "33101419"]}, {"Citation": "Marrazzo P., Angeloni C., Freschi M., Lorenzini A., Prata C., Maraldi T., Hrelia S. Combination of epigallocatechin gallate and sulforaphane counteracts in vitro oxidative stress and delays stemness loss of amniotic fluid stem cells. Oxid. Med. Cell. Longev. 2018;2018:5263985. doi: 10.1155/2018/5263985.", "ArticleIdList": ["10.1155/2018/5263985", "PMC6311758", "30647811"]}, {"Citation": "Pizzuti V., Abruzzo P.M., Chatgilialoglu A., Zia S., Marrazzo P., Petrocelli G., Zannini C., Marchionni C., Poggi P., Simonazzi G., et al. A tailored lipid supplement restored membrane fatty acid composition and ameliorates in vitro biological features of human amniotic epithelial cells. J. Clin. Med. 2022;11:1236. doi: 10.3390/jcm11051236.", "ArticleIdList": ["10.3390/jcm11051236", "PMC8911266", "35268327"]}, {"Citation": "Guida M., Maraldi T., Resca E., Beretti F., Zavatti M., Bertoni L., La Sala G.B., De Pol A. Inhibition of nuclear Nox4 activity by plumbagin: Effect on proliferative capacity in human amniotic stem cells. Oxid. Med. Cell. Longev. 2013;2013:680816. doi: 10.1155/2013/680816.", "ArticleIdList": ["10.1155/2013/680816", "PMC3893878", "24489986"]}, {"Citation": "Yamada N., Miki K., Yamaguchi Y., Takauji Y., Yamakami Y., Hossain M.N., Ayusawa D., Fujii M. Extract of Plumbago zeylanica enhances the growth of hair follicle dermal papilla cells with down-regulation of 5\u03b1-reductase type II. J. Cosmet. Dermatol. 2020;19:3083\u20133090. doi: 10.1111/jocd.13355.", "ArticleIdList": ["10.1111/jocd.13355", "32125089"]}, {"Citation": "Inui S., Itami S. Molecular basis of androgenetic alopecia: From androgen to paracrine mediators through dermal papilla. J. Dermatol. Sci. 2011;61:1\u20136. doi: 10.1016/j.jdermsci.2010.10.015.", "ArticleIdList": ["10.1016/j.jdermsci.2010.10.015", "21167691"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "5", "Day": "2"}, {"Year": "2023", "Month": "5", "Day": "23"}, {"Year": "2023", "Month": "5", "Day": "29"}, {"Year": "2023", "Month": "6", "Day": "28", "Hour": "6", "Minute": "43"}, {"Year": "2023", "Month": "6", "Day": "28", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "6", "Day": "28", "Hour": "1", "Minute": "24"}, {"Year": "2023", "Month": "5", "Day": "31"}], "PublicationStatus": "epublish", "ArticleIdList": ["37374085", "PMC10301567", "10.3390/life13061303", "life13061303"]}}], "PubmedBookArticle": []}